Answers are grounded in this paper and cite their sources.
This analysis examines device regulation by the FDA, highlighting implications of recent device failures and recalls.
The Food and Drug Administration (FDA) is known for its rigor in regulating drugs, not devices. That may be about to change. In recent years, well-publicized device recalls and lawsuits have led to complaints that the FDA does not do enough to keep unsafe devices off the market. The failure of some devices, such as implantable defibrillators, could pose deadly risks.Fundamental differences between devices and drugs have important implications for FDA regulation. A typical device is an engineered product, rather than a chemical compound like a conventional drug or a biologic agent. The effects of a minor modification in . . .
No takes yet. Share an insight, caveat, or question.
Alan M. Garber (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: